Cancellation of state registration. Enap® L Combi

February 13, 2018
Active substances:
Trade names:
ICD-10:
IX.I10-I15.I10    Essential [primary] hypertension
Enap A Combi, lercanidipine with enalapril, essential hypertension, treatment of primary hypertension

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical usemedicinal product (registration certificate LP-002583 dated August 14, 2014 issued by LLC "Krka-RUS", Russia):

Enap® L Combi (trade name of the medicinal product)

Lercanidipine + Enalapril (international non-proprietary or chemical name of the medicinal product)

tablets, film-coated, 10 mg + 10 mg, 10 mg + 20 mg (dosage form, dosage)

Limited Liability Company "KRKA-RUS" (OOO KRKA-RUS), Russia 143500, Moscow Region, Istra, ul. Moscow, 50 (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the owner of the registration certificate of OOO KRKA-RUS, Russia, an application for the cancellation of the state registration of a medicinal product.